For 2025, Hai Duong Medical Supplies JSC (Hai Duong Pharma) is targeting a 26% increase in revenue, with a slight dip in profits, according to the company's AGM documents. The company also plans to propose a bonus share issuance and a roadmap for listing on the Ho Chi Minh Stock Exchange (HOSE).